General Information
|
|
Product
|
Brk Antibody FITC-Conjugated
|
Description
|
FITC-Conjugated Protein-Tyrosine Kinase 6 isoform Antibody
|
Verified Applications
|
ELISA, IP, WB
|
Host
|
Rabbit
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
Immunogen
|
Synthetic peptide taken within amino acid region 400-450 on mouse Protein-Tyrosine Kinase 6 isoform.
|
Accession #
|
NCBI: NP_033210
|
Physical Properties
|
|
Quantity
|
100 µg
|
Volume
|
200 µl
|
Concentration
|
0.5-1.5 µg/µl in antibody stabilization buffer
|
Immunoglobulin
|
IgG
|
Form
|
FITC-Conjugated
|
Purification Method
|
Immobilized antigen affinity chromatography
|
Clonality
|
Polylclonal
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
ELISA
|
1:50,000
|
Immunoprecipitation
|
1:200
|
Western Blot
|
1:2,500-1:5,000
|
Protein
|
Uniprot #
|
Q64434
|
Molecular Function
|
ATP binding
identical protein binding
non-membrane spanning protein tyrosine kinase activity
protein tyrosine kinase activity
signaling receptor binding
|
Subcellular Location
|
Nucleus, Cytoplasm, Membrane, Ruffle
|
Expression
|
Expressed only in epithelial tissues, including the skin and lining of the alimentary canal. Restricted to the cell layers immediately above the proliferative cell zone in these epithelia.
|
Structure
|
The SH3 domain plays a major role in substrate interactions. The SH2 domain of PTK6 plays a role in protein-protein interactions, but is likely more important for the regulation of catalytic activity (By similarity).
|
Alternative Nomenclature
|
Breast tumor kinase antibody
Protein tyrosine kinase 6 antibody
Ptk6 antibody
Tyrosine-protein kinase BRK antibody
|
|
|